Aktie A3C14U ALTEROLA BIOTECH, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Alterola Biotech, Inc.

Aktien

A3C14U

US02152V1035

ABTI

Markt geschlossen - OTC Markets
Andere Börsenplätze
 19:07:46 02.07.2024 		% 5 Tage % 1. Jan.
0.02 USD +21.21% Intraday Chart für Alterola Biotech, Inc. 0.00% +455.56%
20.02. Alterola Biotech, Inc. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 31. Dezember 2023 CI
2023 Alterola Biotech, Inc. meldet Ergebnis für das zweite Quartal und die sechs Monate bis zum 30. September 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!
100% kostenlose Registrierung
Alterola Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Alterola Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
Alterola Biotech, Inc. Announces Executive Changes
Alterola Biotech, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023
Alterola Biotech, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023
Alterola Biotech, Inc. Auditor Raises 'Going Concern' Doubt
Alterola Biotech : Management Change - Form 8-K
ALTEROLA BIOTECH INC. : Change in Directors or Principal Officers (form 8-K)
Bright Green Announces Fourth Quarter 2022 Financial Update
ALTEROLA BIOTECH INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Alterola Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
ALTEROLA BIOTECH INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Alterola Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
ALTEROLA BIOTECH INC. : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers (form 8-K)
Alterola Biotech, Inc. Executive Changes
Alterola Biotech, Inc. Appoints Terry Rafih as A Member of Board of Directors
Bright Green Announces Close of Transaction with Alterola Biotech
Bright Green Corporation completed the acquisition of 25% stake in Alterola Biotech, Inc. (OTCPK : ABTI) from Phytotherapeutix Holdings Limited, Equipped 4 Holdings Limited and T.P.R. Global Service Srl.
ALTEROLA BIOTECH INC. - 10-K/A - Management's Discussion and Analysis of Financial Condition and Results of Operations Forward-Looking Statements
ALTEROLA BIOTECH INC. : Other Events, Financial Statements and Exhibits (form 8-K)
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3C14U Aktie
  4. Nachrichten Alterola Biotech, Inc.
  5. Andere Sprachen